Blog Posts

飛機上可以帶電子煙嗎?

Posted by dajksdhj21 on September 19, 2024 at 10:09pm 0 Comments

飛機上可以攜帶電子煙,電子煙及其配件(尤其是包含鋰電池的部分)不能放在託運行李中,而必須隨身攜帶。以下是一些關鍵原因和相關規定:







🟢禁止託運的原因



鋰電池風險:電子菸通常包含鋰離子電池,這種電池在某些情況下可能會過熱、起火甚至爆炸。將鋰電池放在託運行李中,如果發生問題,機組人員無法及時處理,因此航空公司通常要求將其放在隨身行李中,以便在緊急情況下能夠迅速應對。



國際航空運輸協會(IATA)規定:根據IATA的危險品規定,鋰電池應隨身攜帶,而不是託運。這些規定旨在確保飛行安全,航空公司通常會嚴格遵守這些規定。



🟢具體規定…

Continue

Stepping into the Future: The Role of Technology in Footwear Evolution

Posted by freeamfva on September 19, 2024 at 9:31pm 0 Comments

Stepping into the Future: The Role of Technology in Footwear Evolution



Footwear has come a long way from its humble beginnings as a basic necessity for protecting our feet. Today, technology plays a pivotal role in the evolution of footwear, driving innovation and transforming the industry. This article explores how technological advancements have revolutionized footwear design, production, and functionality, making shoes more than just a fashion statement.



Smart… Continue

The Green Revolution: Sustainable Practices in Luxury Bag Production

Posted by freeamfva on September 19, 2024 at 9:21pm 0 Comments

The Green Revolution: Sustainable Practices in Luxury Bag Production



In the world of fashion, luxury bags have long been symbols of status, craftsmanship, and timeless style. However, as environmental concerns become increasingly pressing, the luxury industry is undergoing a transformation. This article explores how sustainable practices are being integrated into the production of luxury bags, highlighting the efforts of brands to reduce their environmental footprint while… Continue

The Ultimate Guide to Choosing the Perfect Luxury Bag for Every Occasion

Posted by freeamfva on September 19, 2024 at 9:10pm 0 Comments

The Ultimate Guide to Choosing the Perfect Luxury Bag for Every Occasion



In the world of fashion, a luxury bag is more than just an accessory; it’s a statement of style, elegance, and sophistication. Whether you’re attending a formal event, heading to the office, or enjoying a casual day out, the right bag can elevate your entire look. This guide will help you navigate the diverse landscape of luxury bags and choose the perfect one for every occasion.



Understanding… Continue

Autologous Cell Therapy Market Size to Witness Sustained Growth throughout the Forecast Period 2019 - 2027

Transparency Market Research (TMR) has published a new report titled, ‘Autologous cell therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’. According to the report, the global autologous cell therapy market was valued at US$ 7.5 Bn in 2018 and is projected to expand at a CAGR of 18.1% from 2019 to 2027.
Request Sample of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S...
Overview
• Cell therapy also termed as cellular therapy in which cellular components is injected into the patient (body) for better treatment outcome and to reduce side effects. A number of cells are used for cellular therapy treatment procedure such as T cells, stem cells, fibroblast, dendritic cells, chondrocyte etc.
• Autologous cell therapy is an innovative therapeutic intervention in which patient’s own cells are used for the treatment procedure. Cells are cultured/engineered and expanded in-vitro and re introduced in the patient’s body for treatment purpose.
• North America dominated the global autologous cell therapy market in 2018 and the trend is anticipated to continue during the forecast period. Highly structured health care industry, increased usage of autologous cell therapy for treatment of various autoimmune and neurological disorders, and new product launch are expected to drive the market in North America.
• Asia Pacific is likely to be a highly lucrative market for autologous cell therapy and it is expected to expand at a high CAGR during the forecast period
Request for Covid-19 Impact Analysis: https://www.transparencymarketresearch.com/sample/sample.php?flag=c...
Rise in Prevalence of Neurological Disorders & Cancer and Others to Drive Market
• Increase in incidence of neurological disorders, cancer and autoimmune disorders are helps to drive the growth of this market during forecasted period.
• Prevalence of several neurological disorders such as multiple sclerosis, Parkinson's disease, and others are helps to drive the growth of this market during forecasted period. According to Multiple sclerosis Society, in 2019, around 2.3. Mn people living with multiple sclerosis by globally.
• According to Parkinson’s Foundation, more than 10 million people worldwide are living with Parkinson disease.
• Increasing incidence of various type of cancers is another major factor to increase the demand of autologous cell therapy. According to World Health Organization, Cancer is the second leading cause of death globally, and is responsible for an estimated 9.6 million deaths in 2018. Globally, about 1 in 6 deaths is due to cancer.
Bone Marrow Segment to Dominate Market
• Based on Source, the global autologous cell therapy market has been divided into bone marrow, epidermis, and others. The bone marrow segment dominated the global autologous cell therapy market in 2018 and the trend is projected to continue during the forecast period. This is because most of the mesenchymal and hematopoietic stem cells are extracted from the bone marrow. Bone marrow is the hub for most of the stem cells (major products are bone marrow based) and extensive R&D activities for bone marrow derived stem cells boost market growth. High preference and growing demand for bone marrow derived cells are likely to propel the segment in developed regions.
• Epidermis segment is likely to be a highly lucrative market for autologous cell therapy and it is expected to expand at a high CAGR during the forecast period due to growing preference for stem cells/autosomal cells extracted from the skin as it is the largest organ in the body.
Enquiry Before Buying: https://www.transparencymarketresearch.com/sample/sample.php?flag=E...
Neurology Segment to be Highly Lucrative Segment
• In terms of application, the global autologous cell therapy market has been classified into branded neurology, orthopedic, cancer, wound healing, cardiovascular disorders, autoimmune disorders and others.
• The neurology segment dominated the autologous cell therapy market due to high preference for cell therapy products for neurodegenerative diseases, rapid rise of stroke death worldwide, and favorable government support accentuates market growth.
• The cancer segment is expected to expand at a significant CAGR by 2027. This is due to huge product in the pipeline development.
Hospitals Segment to be Highly Lucrative Segment
• In terms of end-user, the global autologous cell therapy market has been classified into hospital, ambulatory centers and research centers.
• The hospitals segment dominated the autologous cell therapy market due to Most of the cell therapy procedures are performed in the hospitals as patient prefer hospital for cell therapy procedures for effective treatment.
• The ambulatory centers segment is expected to expand at a fastest CAGR during the forecast period. This is due to cost-effective treatment as compared to hospitals, shorter waiting time, and rise in number of outpatient surgical procedures.
North America to Dominate Global Market
• In terms of region, the global autologous cell therapy market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global autologous cell therapy market in 2018, followed by Europe.
• North America accounted for major share of the global autologous cell therapy market in 2018. This is attributable to increase in health care infrastructure, technological advancement towards innovative treatment and favorable government support accentuate market growth in the region. The federal government has been encouraging research institutions in making treatment options commercially viable. The FDA has been authorized to provide orphan drug designations to many of the therapies developed for rare diseases using cell therapy.
• The autologous cell therapy market in Asia Pacific is anticipated to expand at a high CAGR from 2019 to 2027. This can be attributed to increasing medical tourism, growing contract research activities, and economic growth of certain emerging countries such as China and India, exhibiting faster growth.
Competitive Landscape
• The global autologous cell therapy market is fragmented in terms of number of players. Key players in the global market include Pharmicell Co., Inc., Castle Creek Biosciences, Inc., Vericel Corporation, Lineage Cell Therapeutics, Inc., BrainStorm Cell Therapeutics, Caladrius Biosciences, Inc., Opexa Therapeutics, Inc., Regeneus Ltd., Takeda Pharmaceutical Company Limited., Sangamo Therapeutics, U.S. Stem Cell, Inc. and other prominent players.
The global autologous cell therapy market has been segmented as follows:
• Global Autologous Cell Therapy Market, by Source
o Bone Marrow
o Epidermis
o Others
• Global Autologous Cell Therapy Market, by Application
o Neurology
o Orthopedic
o Cancer
o Wound Healing (including Skin)
o Cardiovascular Disorders
o Autoimmune Disorders
o Others
• Global Autologous Cell Therapy Market, by End-user
o Hospitals
o Ambulatory Centers
o Research Centers
About Us Section:
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!
Contact Us
Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: [email protected]
Website: https://www.transparencymarketresearch.com/

Views: 1

Comment

You need to be a member of On Feet Nation to add comments!

Join On Feet Nation

© 2024   Created by PH the vintage.   Powered by

Badges  |  Report an Issue  |  Terms of Service